S&P Biotech index suffered a rare, severe one-day drop. Guy LeBas called it a 2-standard-deviation move, saying only a handful of sessions since 2017 were worse, highlighting the scale of the sector selloff.
published
S&P Biotech index suffered a rare, severe one-day drop. Guy LeBas called it a 2-standard-deviation move, saying only a handful of sessions since 2017 were worse, highlighting the scale of the sector selloff.
Latest documented BWB result
$NVDA market result
Exit $NVDA with $3 profit per share
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.